Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

NCT02558413 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Healthy Volunteers

Interventions

DRUG: BTA-C585 oral capsules
DRUG: BTA-C585 matching placebo

Sponsor

Biota Pharmaceuticals, Inc.